Published in Cancer Weekly, May 8th, 2001
The series of trials is anticipated to involve a total of approximately 40 to 60 patients depending upon the number of treatment regimens tested and will include an evaluation of GVAX prostate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.